Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience (original) (raw)
Impact of Routine Surveillance Imaging on Outcomes in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)
Narendranath Epperla
Blood, 2015
View PDFchevron_right
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls
Brad Pohlman
British Journal of Haematology, 2011
View PDFchevron_right
Autologous Hematopoietic Stem Cell Transplantation is an Effective Treatment Option in Early Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma
Eloísa Riva
Journal of Bone Marrow Transplantation and Cellular Therapy, 2023
View PDFchevron_right
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
J. Maertens
Bone Marrow Transplantation, 2019
View PDFchevron_right
Autologous Stem Cell Transplantation in Refractory or Relapsed Diffuse Large B Cell Lymphoma - a Single Centre Experience
Ana Planinc-peraica
Liječnički vjesnik, 2015
View PDFchevron_right
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes
Delphine Maucort-boulch
Hematological oncology, 2018
View PDFchevron_right
Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation
Narendranath Epperla
Blood Advances
View PDFchevron_right
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation
Urs Schanz
Swiss medical weekly, 2013
View PDFchevron_right
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma
Corinne Haioun
Annals of Oncology, 2009
View PDFchevron_right
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy
John Seymour
British Journal of Haematology, 2000
View PDFchevron_right
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma
Elena Perez-ceballos
Cancer medicine, 2017
View PDFchevron_right
Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma: A Single Portuguese Center Experience
Fernando Campilho
Acta médica portuguesa, 2016
View PDFchevron_right
Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Jacques-olivier Bay
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation
ANDY CHEN
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014
View PDFchevron_right
R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma
Hong Jun Lee
Blood research, 2014
View PDFchevron_right
Safety in Relapsed / Refractory Diffuse Large B-Cell Lymphoma : A Systematic Literature Review
Adeline Abbe
2014
View PDFchevron_right
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation
Luis Porrata
British Journal of Haematology, 2008
View PDFchevron_right
Prognostic impact of pre-transplantation computed tomography and 67 gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation
ignacio escobar
Annals of Nuclear Medicine, 2008
View PDFchevron_right
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study
Vladimir Lazarevic
Leukemia & Lymphoma, 2012
View PDFchevron_right
The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings
Celso Rodrigues
Current Hematologic Malignancy Reports, 2010
View PDFchevron_right
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
David Linch
Journal of Clinical Oncology, 2010
View PDFchevron_right
Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease
Wyndham Wilson
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2005
View PDFchevron_right
Favourable outcomes of poor prognosis diffuse large B-cell lymphoma patients treated with dose-dense Rituximab, high-dose Methotrexate and six cycles of CHOP-14 compared to first-line autologous transplantation
Roland Mertelsmann
British Journal of Haematology, 2017
View PDFchevron_right
Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
R. Lowenthal
Journal of Clinical Oncology, 2012
View PDFchevron_right
Detection of second primary lymphoma in late diffuse large B-cell lymphoma recurrences
Konnie Hebeda
View PDFchevron_right
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index
Robert Zeiser
Annals of Oncology, 2004
View PDFchevron_right
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study
Luigi Rigacci
Annals of Hematology, 2012
View PDFchevron_right